https://www.avient.com/sites/default/files/resources/Tangerang_ISO22000.pdf
Müller, CEO SQS
6
6
6
0
_
2
/ J
u
n
e
2
0
19
/ V
er
si
o
n
2
.0
Swiss Association for Quality
and Management Systems (SQS)
Bernstrasse 103, 3052 Zollikofen, Switzerland
A.
https://www.avient.com/sites/default/files/resources/Jurong_ISO22000.pdf
Müller, CEO SQS
6
6
6
0
_
2
/ J
u
n
e
2
0
19
/ V
er
si
o
n
2
.0
Swiss Association for Quality
and Management Systems (SQS)
Bernstrasse 103, 3052 Zollikofen, Switzerland
A.
https://www.avient.com/sites/default/files/2021-10/microbial-susceptibility-of-various-polymers-and-evaluation.pdf
To prepare samples with an active ingredient, a linear
low-density poly(ethylene) masterbatch “AMPE 143101”
2 ZANDER ET AL.
Figure 2 shows
the performance of a select series of Versaflex™ and
OnFlex™ GLS™ TPEs with a range of ZPT additive
(1000–3000 ppm).
Inoguchi, IHS Markit;
Specialty Chemicals Update Program 2020, 1, 10.
[2] N.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-may-2021-w-non-gaap-recs.pdf
Microsoft PowerPoint - Avient IR Presentation - May 2021
AVIENT CORPORATION
M A Y 2 0 2 1 I N V E S T O R M E E T I N G S
(NYSE: AVNT)
D I S C L A I M E R
2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Reduce Scope 1 & 2 greenhouse gas
emissions by 35%.
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
26
Capex / Revenue
2021E (%)
AV I E N T I S A SS E T L I G H T
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2 3 2 2 2
3 3
4 3 3 3
4 4 5
5 5 6
7 7
8
24
A
vi
e
n
t
A
vi
e
n
t
(E
xc
l.
https://www.avient.com/investor-center/news/avient-announces-record-fourth-quarter-and-full-year-2021-results
Attachment 2
Tax adjustments(2)
2)
https://www.avient.com/sites/default/files/2024-03/AVNT February IR Presentation_w_Non-GAAP Recs_v2.pdf
Avient corporation first quarter 2023 results
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
F E B R U A R Y 2 0 2 4
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Continue fostering our Great
Place to Work® culture
Strategic Objectives
Long Term
Growth
Rates
Growth Drivers
$340
$455
$790
$1,135
2016 2018 2020 2023
$51
$84
$212
$645
2016 2018 2020 2023
$108 $113
$231 $230
2016 2018 2020 2023
$265
$358
$726 $725
2016 2018 2020 2023
8-12% 8-10% 8-10% 5%
Sustainable Solutions Composites Healthcare Asia/Emerging Regions
Profitable Growth Great Place to Work
5.4%
10.9%
16.0%
2006 2014 2023
EBITDA Margins
$0.14
$1.93
$2.36
2006 2014 2023
Adjusted EPS
TOP -T IE R S US TAINABIL IT Y P E RF ORM ANCE
AND RE COGNIT ION
Industry Sustainability Standards
ESG Ratings Performance
1
2
4
87th
94th
percentile
5
Avient CDP Score:
A-
F E B R U A R Y 1 4 , 2 0 2 4
W E B C A S T
P R E S E N T AT I O N
DR.
PY
( T O TA L C O M PA N Y )
$790
$719
2022 2023
$107
$114
2022 2023
Sales Adjusted EBITDA
(in millions)
$0.42
$0.52
2022 2023
Adjusted EPS
(in millions)
- 9% + 7% + 24%
Sales Adjusted EBITDA Adjusted EPS
15
Q4 2023 SEGMENT PERFORMANCE
16
CAI
$491
$459
Sales
(in millions)
$70
$84
EBITDA
SEM
$301
$260
Sales
$55
$49
EBITDA
- 7% - 14%+20% - 11%
2022 2023
(in millions)
Q4 EBITDA BRIDGE
( T O TA L C O M PA N Y )
17
$ millions
CAI:
Price / Mix 11
Deflation 14
SEM:
Price / Mix 4
Deflation 9
Net Price Benefit 38
Cost Reductions 13
Wage Inflation (8)
Other (2)
Q4 2023 $114
Adjusted
EBITDA
Q4 2022 $ 107
Demand (34) • Demand was down, but less than in previous
quarters, due to slowing pace of destocking
• Positive net price benefit:
o CAI – Pricing flat with favorable mix from
uptick in packaging and consumer end
markets and raw material deflation
o SEM - Pricing flat with favorable mix from
Composites and raw material deflation
• Cost reductions primarily driven by reduced
administrative costs and cost synergies
2 0 2 4 G U I D A N C E
2024 GUIDANCE
Full Year 2024 Guidance
Adjusted EBITDA $505 to $535 million
Adjusted EPS $2.40 to $2.65
Interest Expense $105 to $110 million
Adjusted Effective Tax Rate 23% to 25%
Capital Expenditures ~$140 million
19
Q1 Adjusted EPS of $0.68
A P P E N D I X
21
Performance
Additives
15%
Pigments
13%
TiO2
9%
Dyestuffs
2%
Polyethylene
10%Nylon
5%
Polypropylene
4%
Styrenic Block
Copolymer
4%
Other Raw
Materials
38%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
RA W MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
41%
EMEA
36%
Asia
18%
Latin America
5%
2023 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Consumer
19%
Packaging
23%Industrial
16%
Building and
Construction
9%
Telecommunications
4%
Energy
5%
Defense
7%
END MARKET REVENUE
$2,007M $358M
$1,138M $224M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$502M$3,143M
(1)
Transportation
10%
Healthcare
7%
23
(1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs
2 0 2 3 R E V E N U E | $ 2 . 0 B I L L I O N
US & Canada
34%
EMEA
37%
Asia
21%
Latin America
8%
END MARKET REGION
24
Packaging
34%
Consumer
21%
Healthcare
8%
Industrial
15%
Transportation
9%
Building &
Construction
10%
Telecommunications
1% Energy
2%
COLOR, ADDITIVES & INKS
2 0 2 3 R E V E N U E | $ 1 . 1 B I L L I O N
US & Canada
52%
EMEA
35%
Asia
13%
25
Packaging
5%
Consumer
16%
Healthcare
6%Industrial
16%
Transportation
12%
Telecommunications
9%
Energy
10% Defense
18%
Building &
Construction
8%
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
Packaging
32%
Consumer
26%
Healthcare
9%
Industrial
13%
Building &
Construction
6%
Telecommunications
2%
Energy
2% Defense
1%
Asia
(18% of sales)
Transportation
9%
2 0 2 3 AV I E N T R E G I O N A L S A L E S
Packaging
25%
Consumer
13%
Healthcare
5%
Industrial
18%
Building &
Construction
9%
Energy
5%
Defense
8%
EMEA
(36% of sales)Transportation
13%
Packaging
13%
Consumer
22%
Healthcare
10%
Industrial
16%
Building &
Construction
12%
Energy
6%
Defense
8%
US &
Canada
(41% of sales)
Transportation
9%
Packaging
59%
Consumer
22%
Healthcare
2%
Industrial
8%
Building &
Construction
4%
LATAM
(5% of sales)
Transportation
5%
Telecommunications
4%
Telecommunications
4%
26
B Y E N D M A R K E T
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2020-10/investing-in-avient.pdf
Microsoft PowerPoint - Investing in Avient - V17 - the MASTER
AVIENT CORPORATION
(NYSE: AVNT)
O C T O B E R 2 0 2 0
D I S C L A I M E R
2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
PEER COMPARISONS
16
2 3 2 3 3 3
6
3 4
4 4 4 5
5 6 6
7
8
9
23
A
vi
e
n
t
A
vi
e
n
t
(E
xc
l.
SEGMENT HIGHLIGHTS
Packaging
37%
Consumer
22%
Healthcare
8%
Industrial
14%
Building &
Construction
8%
Transportation
6%
Wire & Cable
3%
Electrical &
Electronics
2%
C O L O R , A D D I T I V E S & I N K S
2 0 2 0 P F R E V E N U E | $ 2 . 0 B I L L I O N
$9
$310
2.0%
15.5%
2020 figures Pro forma estimates for acquisition of the Clariant Masterbatch business
US & Canada
32%
Europe
39%
Asia
23%
Latin America
6%
END MARKET REGION EBITDA DOLLAR & MARGIN
EXPANSION
24
US & Canada
59%
Europe
23%
Asia
18%
Consumer
23%
Healthcare
10%
Packaging
6%
Wire & Cable(1)
25%
Electrical &
Electronics
14%
Industrial
10%
Transportation
10%
Building &
Construction
2%
S P E C I A L T Y E N G I N E E R E D M A T E R I A L S
2 0 2 0 E R E V E N U E | $ 6 8 5 M I L L I O N
0.9%
16.8%
END MARKET REGION EBITDA DOLLAR & MARGIN
EXPANSION
25
(1) Approximately 50% of Wire and Cable sales are associated with Fiber Optic Cabling
Healthcare
30%
Consumer
24%Packaging
3%
Industrial
19%
Transportation
15%
Electrical &
Electronics
4%
Building &
Construction
4%
Wire & Cable
1%
US & Canada
79%
Asia
2%
Latin
America
19%
END MARKET REGION EBITDA DOLLAR & MARGIN
EXPANSION
D I S T R I B U T I O N
2 0 2 0 E R E V E N U E | $ 1 . 0 5 B I L L I O N
$20
$65
2.9%
6.2%
K E Y S U P P L I E R S
26
AMERICAS EUROPE ASIA
Consumer
26%
Healthcare
19%
Packaging
13%
Industrial
16%
Wire & Cable
7%
Building &
Construction
5%
Electrical &
Electronics
4%
Packaging
35%
Consumer
14%Healthcare
6%
Industrial
17%
Wire & Cable
10%
Building &
Construction
8%
Electrical &
Electronics
3%
Packaging
32%
Consumer
26%
Healthcare
12%
Industrial
7%
Wire & Cable
6%
Building &
Construction
4%
Electrical &
Electronics
9%
Transportation
10%
Transportation
7%
Transportation
4%
2020 figures Pro forma estimates for acquisition of the Clariant Masterbatch business
T O T A L C O M PA N Y R E G I O N A L S A L E S
B Y E N D M A R K E T
(58% of sales) (25% of sales) (17% of sales)
27
https://www.avient.com/sites/default/files/2024-03/2024 Proxy Statement %28Filed%29.pdf
Garratt
2/08/2021 — — — — — 5,417 225,185
2/14/2022 — — — — — 4,794 199,287
2/17/2023 — — — — — 5,701 236,991
2/04/2015 9,200 — — 38.27 2/04/2025 — —
2/15/2017 13,250 — — 34.10 2/15/2027 — —
2/14/2018 11,050 — — 41.89 2/14/2028 — —
2/11/2019 18,200 — — 31.54 2/11/2029 — —
2/10/2020 19,650 — — 31.48 2/10/2030 — —
2/08/2021 13,433 6,717 — 42.27 2/08/2031 — —
2/14/2022 — — 16,000 52.64 2/14/2032 — —
2/17/2023 — — 18,800 42.93 2/17/2033 — —
J.R.
Rathbun
2/08/2021 — — — — — 5,417 225,185
2/14/2022 — — — — — 4,794 199,287
2/17/2023 — — — — — 7,036 292,487
2/4/2015 2,500 — — 38.27 2/4/2025 — —
2/10/2016 10,400 — — 24.98 2/10/2026 — —
2/15/2017 10,100 — — 34.10 2/15/2027 — —
2/14/2018 10,400 — — 41.89 2/14/2028 — —
2/11/2019 17,150 — — 31.54 2/11/2029 — —
2/10/2020 19,200 — — 31.48 2/10/2030 — —
2/08/2021 13,433 6,717 — 42.27 2/08/2031 — —
2/14/2022 — — 16,000 52.64 2/14/2032 — —
2/17/2023 — — 23,250 42.93 2/17/2033 — —
L.K.
Kunkle (3)
2/08/2021 — — — — — 5,792 240,773
2/14/2022 — — — — — 5,425 225,517
2/17/2023 — — — — — 6,470 268,958
2/15/2017 12,100 — — 34.10 2/15/2027 — —
2/14/2018 11,500 — — 41.89 2/14/2028 — —
2/11/2019 19,250 — — 31.54 2/11/2029 — —
2/10/2020 21,200 — — 31.48 2/10/2030 — —
2/08/2021 14,433 7,217 — 42.27 2/08/2031 — —
2/14/2022 — — 18,050 52.64 2/14/2032 — —
2/17/2023 — — 21,250 42.93 2/17/2033 — —
R.M.
https://www.avient.com/sites/default/files/2022-08/Avient CDP_Climate_Change_Questionnaire_2022.pdf
Row 1
Scope 2, location-based
We are reporting a Scope 2, location-based figure
Scope 2, market-based
We are reporting a Scope 2, market-based figure
Comment
C6.3
(C6.3) What were your organization’s gross global Scope 2 emissions in metric tons
CO2e?
Reporting year
Scope 2, location-based
134,244
Scope 2, market-based (if applicable)
85,892
Comment
C6.4
(C6.4) Are there any sources (e.g. facilities, specific GHGs, activities, geographies,
etc.) of Scope 1 and Scope 2 emissions that are within your selected reporting
boundary which are not included in your disclosure?
Other
C7.9b
(C7.9b) Are your emissions performance calculations in C7.9 and C7.9a based on a
location-based Scope 2 emissions figure or a market-based Scope 2 emissions
figure?
https://www.avient.com/sites/default/files/2022-09/Avient Pro Forma Financial Information.pdf
AVIENT CORPORATION
P R O F O R M A F I N A N C I A L S F O R D Y N E E M A
A C Q U I S I T I O N A N D D I S T R I B U T I O N A S
D I S C O N T I N U E D O P E R A T I O N S
(NYSE: AVNT)
S E P T E M B E R 2 7 , 2 0 2 2
DISCLAIMER
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Additionally, Adjusted EPS excludes the impact of special
items and amortization expense associated with intangible assets.
2
PRO FORMA 2021 TO 2022 BRIDGE
3
2021 EPS from Continuing Operations 1.69$
Pro Forma & Special Items 1.33
Proforma 2021 Adjusted EPS 3.02$
FX Impact (0.22)
China Lockdowns / Russia Import Sales (0.24)
Outdoor High Performance (0.13)
Dyneema 0.06
Color, Additives and Inks 0.38
Legacy Specialty Engineered Materials 0.22
Other 0.01
Proforma 2022 Adjusted EPS 3.10$
Constant Currency Sales
Sales
COLOR, ADDITIVES AND INKS
Q1 Q2 Q3 Q4 FY
4%
Q1 Q2 Q3 Q4 FY
4%
7% (4%) (9%)
6% (10%)
0% 1%
2%
Constant currency reflects prior year results restated at current year foreign exchange rates
Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY
7%
10% 4% (3%)
12% (6%)
5% 6%
9%
610 650 624 649 587 565 581 526
2,402 2,390
589 650 589 649 543 565 545 526
2,266 2,390
116 121 112 119 93 95 88 79
409 414
113 121 106 119 87 95 84 79
390 414
Constant Currency EBITDA
EBITDA
10%
4
Constant Currency EBITDA
Sales
Q1 Q2 Q3 Q4 FY
(1%)
PRO FORMA SPECIALTY ENGINEERED MATERIALS
Q1 Q2 Q3 Q4 FY
16%8% (8%) (8%)
3% (6%) (6%)
(2%) 2%
EBITDA
Constant Currency Sales
Constant currency reflects prior year results restated at current year foreign exchange rates
Q1 Q2 Q3 Q4 FY
4%
Q1 Q2 Q3 Q4 FY
20%12% (1%) (2%)
5% (1%) (2%)
3% 6%
314 338 348 343 325 300 321 295
1,308 1,276
303 338 329 343 303 300 301 295
1,236 1,276
67 78 75 77 70 66 66 62
278 283
65 78 73 77 67 66 63 62
268 283
5
Constant Currency Adjusted EPS
Adjusted EPS
PRO FORMA AVIENT
Q1 Q2 Q3 Q4 FY
10% (3%) (21%)
3%
Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY
9% 5%
7% (5%) (9%)
(1%)
(1%) (12%)
1%
Sales
Constant Currency Sales
Constant currency reflects prior year results restated at current year foreign exchange rates
Q1 Q2 Q3 Q4 FY
17% 8% (14%)
11%
Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY
14% 10%
11% 2% (3%)
5%
8% (5%)
7%
EBITDA
Constant Currency EBITDA
925 987 973 992 912 867 902 823
3,712 3,669
893 987 919 992 847 867 845 823
3,504 3,669
161 176 164 172 142 141 133 117
600 606
155 176 157 172 131 141 123 117
566 6068%
2%
0.84 0.98 0.87 0.96 0.70 0.68 0.61 0.48
3.02 3.10
0.79 0.98 0.82 0.96 0.63 0.68 0.56 0.48
2.80 3.10
17%
24%
6
Three Months Ended
March 31, 2022
Three Months Ended
March 31, 2021
Reconciliation to Condensed Consolidated Statements of Income Avient EPS Avient EPS
Net income from continuing operations $ 64.7 $ 60.4
Net income attributable to noncontrolling interests (0.3) (0.4)
Net income from continuing operations attributable to Avient shareholders $ 64.4 $ 0.70 $ 60.0 $ 0.65
Special items, after tax $ 6.4 $ 0.07 $ 2.6 $ 0.03
APM pro forma adjustments 2.6 0.03 (3.1) (0.03)
Amortization expense, after tax 17.4 0.19 17.9 0.19
Adjusted pro forma net income / EPS $ 90.8 $ 0.98 $ 77.4 $ 0.84
Weighted average diluted shares 92.3 92.2
Three Months Ended
June 30, 2022
Three Months Ended
June 30, 2021
Reconciliation to Condensed Consolidated Statements of Income Avient EPS Avient EPS
Net income from continuing operations $ 62.8 $ 50.2
Net income attributable to noncontrolling interests — (0.6)
Net income from continuing operations attributable to Avient shareholders $ 62.8 $ 0.68 $ 49.6 $ 0.54
Special items, after tax $ 3.2 $ 0.03 $ 11.7 $ 0.13
APM pro forma adjustments 5.2 0.06 1.4 0.02
Amortization expense, after tax 17.2 0.19 17.8 0.19
Adjusted pro forma net income / EPS $ 88.4 $ 0.96 $ 80.5 $ 0.87
Weighted average diluted shares 92.1 92.4
Three Months Ended
September 30, 2021
Reconciliation to Condensed Consolidated Statements of Income Avient EPS
Net income from continuing operations $ 33.4
Net income attributable to noncontrolling interests 0.3
Net income from continuing operations attributable to Avient shareholders $ 33.7 $ 0.37
Special items, after tax $ 11.7 $ 0.13
APM pro forma adjustments 1.5 0.02
Amortization expense, after tax 17.6 0.19
Adjusted pro forma net income / EPS $ 64.5 $ 0.70
Weighted average diluted shares 92.2
Adjusted EPS may not recalculate due to rounding.
1
Three Months Ended
December 31, 2021
Year Ended
December 31, 2021
Reconciliation to Condensed Consolidated Statements of Income Avient EPS Avient EPS
Net income from continuing operations $ 11.2 $ 155.2
Net income attributable to noncontrolling interests 0.9 0.2
Net income from continuing operations attributable to Avient shareholders $ 12.1 $ 0.13 $ 155.4 $ 1.69
Special items, after tax $ 24.0 $ 0.26 $ 50.0 $ 0.54
APM pro forma adjustments 2.5 0.03 1.6 0.02
Amortization expense, after tax 17.8 0.19 71.1 0.77
Adjusted pro forma net income / EPS $ 56.4 $ 0.61 $ 278.1 $ 3.02
Weighted average diluted shares 92.4 92.1
Reconciliation of Color, Additives and Inks EBITDA
Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022
Operating
Income 88.8 86.3 66.8 61.2 303.1 94.5 93.6
Depreciation and
amortization 27.4 25.3 26.6 26.4 105.7 26.0 25.9
EBITDA $ 116.2 $ 111.6 $ 93.4 $ 87.6 $ 408.8 $ 120.5 $ 119.5
Reconciliation of Specialty Engineered Materials EBITDA
Q1 2021 Q2 2021 Q3 2021
SEM
Pro
forma
APM
Pro
forma
SEM SEM
Pro
forma
APM
Pro
forma
SEM SEM
Pro
forma
APM
Pro
forma
SEM
Operating Income 32.6 9.1 41.7 35.8 13.9 49.7 30.0 15.2 45.2
Depreciation and
amortization 7.8 17.5 25.3 8.1 17.3 25.4 7.9 17.1 25.0
EBITDA $ 40.4 $ 26.6 $ 67.0 $ 43.9 $ 31.2 $ 75.1 $ 37.9 $ 32.3 $ 70.2
Reconciliation of Specialty Engineered Materials EBITDA
Q4 2021 YTD 2021
SEM
Pro
forma
APM
Pro
forma
SEM SEM
Pro
forma
APM
Pro
forma
SEM
Operating Income 27.1 11.7 38.8 125.5 49.9 175.4
Depreciation and amortization 8.0 18.9 26.9 31.8 70.8 102.6
EBITDA $ 35.1 $ 30.6 $ 65.7 $ 157.3 $ 120.7 $ 278.0
2
Reconciliation of Specialty Engineered Materials EBITDA
Q1 2022 Q2 2022
SEM
Pro
forma
APM
Pro
forma
SEM SEM
Pro
forma
APM
Pro
forma
SEM
Operating Income 38.3 15.4 53.7 35.2 17.7 52.9
Depreciation and amortization 7.8 16.6 24.4 7.7 16.6 24.3
EBITDA $ 46.1 $ 32.0 $ 78.1 $ 42.9 $ 34.3 $ 77.2
Reconciliation of Avient consolidated pro forma EBITDA
Q1 2021 Q2 2021 Q3 2021
Avient
Pro
forma
APM
Pro
forma
Avient Avient
Pro
forma
APM
Pro
forma
Avient Avient
Pro
forma
APM
Pro
forma
Avient
Net income from
continuing operations 60.4 (3.1) 57.3 50.2 1.4 51.6 33.4 1.5 34.9
Income tax expense 16.3 1.1 17.4 13.8 1.3 15.1 2.0 2.5 4.5
Interest expense 19.3 11.1 30.4 19.5 11.2 30.7 19.0 11.2 30.2
Depreciation and
amortization 36.9 17.5 54.4 33.6 17.3 50.9 36.6 17.1 53.7
EBITDA 132.9 26.6 159.5 117.1 31.2 148.3 91.0 32.3 123.3
Special items, before
tax 2.4 — 2.4 14.2 — 14.2 19.9 — 19.9
Depreciation included
in special items (0.6) — (0.6) 1.4 — 1.4 (0.9) — (0.9)
Adjusted EBITDA $ 134.7 $ 26.6 $ 161.3 $ 132.7 $ 31.2 $ 163.9 $ 110.0 $ 32.3 $ 142.3
Reconciliation of Avient consolidated pro forma EBITDA
Q4 2021 YTD 2021
Avient
Pro
forma
APM
Pro
forma
Avient Avient
Pro
forma
APM
Pro
forma
Avient
Net income from continuing operations 11.2 2.5 13.7 155.2 1.6 156.8
Income tax expense 16.2 (1.9) 14.3 48.3 3.7 52.0
Interest expense 17.5 11.1 28.6 75.3 44.6 119.9
Depreciation and amortization 37.9 18.9 56.8 145.0 70.8 215.8
EBITDA 82.8 30.6 113.4 423.8 120.7 544.5
Special items, before tax 20.6 — 20.6 57.1 — 57.1
Depreciation included in special items (1.6) — (1.6) (1.7) — (1.7)
Adjusted EBITDA $ 101.8 $ 30.6 $ 132.4 $ 479.2 $ 120.7 $ 599.9
3
Reconciliation of Avient consolidated pro forma EBITDA
Q1 2022 Q2 2022
Avient
Pro
forma
APM
Pro
forma
Avient Avient
Pro
forma
APM
Pro
forma
Avient
Net income from continuing operations 64.7 2.6 67.3 62.8 5.2 68.0
Income tax expense 20.0 1.7 21.7 22.7 1.4 24.1
Interest expense 16.9 11.1 28.0 16.2 11.1 27.3
Depreciation and amortization 37.6 16.6 54.2 36.3 16.6 52.9
EBITDA 139.2 32.0 171.2 138.0 34.3 172.3
Special items, before tax 6.6 — 6.6 0.9 — 0.9
Depreciation included in special items (2.1) — (2.1) (1.1) — (1.1)
Adjusted EBITDA $ 143.7 $ 32.0 $ 175.7 $ 137.8 $ 34.3 $ 172.1
Reconciliation of Specialty Engineered Pro Forma Sales
Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022
Sales 214.7 238.9 231.7 226.3 911.6 243.1 242.3
Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5
Pro forma sales $ 313.6 $ 347.7 $ 325.5 $ 321.2 $ 1,308.0 $ 337.9 $ 342.8
Reconciliation of Avient Pro Forma Sales
Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022
Sales 826.0 864.5 818.0 807.1 3,315.6 892.2 891.0
Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5
Pro forma sales $ 924.9 $ 973.3 $ 911.8 $ 902.0 $ 3,712.0 $ 987.0 $ 991.5
4
IR Slides
V17 - 9.26 324pm IR Deck - AVNT-2022.09.27 Pre Release v2